{"id":"https://openalex.org/W4388047985","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0493","title":"493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models","display_name":"493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047985","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0493"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0493","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0493","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0493","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A555.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/11/Suppl_1/A555.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070953467","display_name":"Ir\u00e8ne Baccelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ir\u00e8ne Baccelli","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109591004","display_name":"Caroline Mary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Mary","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064397939","display_name":"St\u00e9phanie Neyton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Neyton","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Myl\u00e8ne Deram\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Myl\u00e8ne Deram\u00e9","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033137419","display_name":"Marion Drouin","orcid":"https://orcid.org/0000-0001-7984-318X","observed_orcids":["https://orcid.org/0000-0001-7984-318X"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marion Drouin","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087659024","display_name":"G\u00e9raldine Teppaz","orcid":"https://orcid.org/0000-0002-5835-2493","observed_orcids":["https://orcid.org/0000-0002-5835-2493"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Geraldine Teppaz","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022705054","display_name":"Emmanuelle Wilhelm","orcid":"https://orcid.org/0000-0003-2506-2892","observed_orcids":["https://orcid.org/0000-0003-2506-2892"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emmanuelle Wilhelm","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000095429","display_name":"Isabelle Girault","orcid":"https://orcid.org/0000-0002-9587-5197","observed_orcids":["https://orcid.org/0000-0002-9587-5197"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Girault","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012547336","display_name":"Vanessa Gauttier","orcid":"https://orcid.org/0000-0002-4297-0449","observed_orcids":["https://orcid.org/0000-0002-4297-0449"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vanessa Gauttier","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032120204","display_name":"Virginie Th\u00e9penier","orcid":"https://orcid.org/0000-0003-3675-9281","observed_orcids":["https://orcid.org/0000-0003-3675-9281"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Virginie Thepenier","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046464434","display_name":"C\u00e9cile Batty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cecile Batty","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075730887","display_name":"K\u00e9vin Biteau","orcid":"https://orcid.org/0009-0004-4391-2701","observed_orcids":["https://orcid.org/0009-0004-4391-2701"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Kevin Biteau","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061233816","display_name":"Ariane Desselle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ariane Desselle","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marion Colonello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marion Colonello","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028129441","display_name":"Julien Taurelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julien Taurelle","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085761569","display_name":"Marine Malloci","orcid":"https://orcid.org/0000-0002-9858-8716","observed_orcids":["https://orcid.org/0000-0002-9858-8716"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marine Malloci","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051368680","display_name":"Elise Chiffoleau","orcid":"https://orcid.org/0000-0001-6167-682X","observed_orcids":["https://orcid.org/0000-0001-6167-682X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210112643","display_name":"Institut de Transplantation Urologie en Nephrologie","ror":"https://ror.org/02dm0bq25","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210105774","https://openalex.org/I4210112643"]},{"id":"https://openalex.org/I4392021198","display_name":"Center for Research in Transplantation and Translational Immunology","ror":"https://ror.org/01165k395","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4392021198","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elise Chiffoleau","raw_affiliation_strings":["Nantes Universit\u00e9, Inserm, Centre de Recherche en Transplantation et Immunologie Translationnelle, UMR 1064, ITUN, Nantes, Loire Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes Universit\u00e9, Inserm, Centre de Recherche en Transplantation et Immunologie Translationnelle, UMR 1064, ITUN, Nantes, Loire Atlantique, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210112643","https://openalex.org/I4392021198","https://openalex.org/I97188460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048543389","display_name":"Nicolas Poirier","orcid":"https://orcid.org/0000-0003-2335-9385","observed_orcids":["https://orcid.org/0000-0003-2335-9385"]},"institutions":[{"id":"https://openalex.org/I4210101439","display_name":"OSE Immunotherapeutics (France)","ror":"https://ror.org/00p3g3670","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210101439"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Poirier","raw_affiliation_strings":["OSE Immunotherapeutics, Nantes, Loire-Atlantique, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OSE Immunotherapeutics, Nantes, Loire-Atlantique, France","institution_ids":["https://openalex.org/I4210101439"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A555","last_page":"A555"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6366999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.6366999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3061999976634979,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.03220000118017197,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-type-lectin-receptors","display_name":"C-type lectin receptors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/immune-checkpoint","display_name":"immune checkpoint","score":0.527999997138977},{"id":"https://openalex.org/keywords/trim21","display_name":"TRIM21","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dendritic-cell-cross-presentation","display_name":"dendritic cell cross-presentation","score":0.746999979019165},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7803860902786255},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5430386662483215},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.501894474029541},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4945997893810272},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48140454292297363},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3517732620239258},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2016516625881195}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0493","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0493","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0493","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A555.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:45af6b22c7b64833b57d18e90b652885","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/45af6b22c7b64833b57d18e90b652885","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0493","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0493","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0493","pdf_url":"https://jitc.bmj.com/content/11/Suppl_1/A555.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047985.pdf","grobid_xml":"https://content.openalex.org/works/W4388047985.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W3006833178","https://openalex.org/W4309469472"],"related_works":["https://openalex.org/W4393071912","https://openalex.org/W4409635188","https://openalex.org/W3213120122","https://openalex.org/W4379984547","https://openalex.org/W4308398689","https://openalex.org/W4309469472","https://openalex.org/W3103965924","https://openalex.org/W3179393169","https://openalex.org/W3083253864","https://openalex.org/W6987046988"],"abstract_inverted_index":{"Background":[0],"The":[1],"c-type":[2],"lectin":[3],"receptor":[4,10],"CLEC-1":[5,28,38,41,70,83,90,130,146,181,187,214,222,235,257,270,325,373],"is":[6,228,374],"a":[7,119,338,375,387],"pattern":[8],"recognition":[9],"1":[11],"expressed":[12],"by":[13,53,95,100,302,382],"endothelial":[14],"and":[15,22,63,73,111,127,162,173,197,211,284,333,340,385],"myeloid":[16,323],"cells":[17,384],"in":[18,29,77,169,326,359,409],"mice,":[19],"non-human":[20],"primates,":[21],"humans.":[23],"While":[24,184],"genetic":[25],"deletion":[26,39],"of":[27,69,82,121,145,155,221,246,249,256,269,289,309,319,321],"mice":[30,291],"does":[31,232],"not":[32,233],"lead":[33],"to":[34,85,141,147,190,198,223,237,259,272,296,329],"any":[35],"developmental":[36],"defect,":[37],"or":[40,48,357],"targeting":[42],"using":[43,179],"monoclonal":[44,123,252],"antibodies":[45,124,134,158],"increases":[46,265,285],"damaged":[47],"necrotic":[49],"cell":[50,212],"antigen":[51,380],"cross-presentation":[52,381],"cDC1":[54],"dendritic":[55,383],"cells,":[56],"as":[57,59,230,294,337],"well":[58],"subsequent":[60],"T-cell":[61],"activation":[62],"anti-tumor":[64,167,266,331],"response.2":[65],"However,":[66],"the":[67,78,143,191,199,219,243,286,307,317,322],"identification":[68],"endogenous":[71,151],"ligands":[72,227,276],"their":[74,139,166],"relative":[75],"involvement":[76],"immune":[79],"checkpoint":[80,324],"activity":[81],"remained":[84],"be":[86],"fully":[87],"investigated.Methods":[88],"Endogenous":[89],"ligand":[91,262,311],"candidates":[92,104],"were":[93,105,135,159],"identified":[94,150,161,226],"affinity":[96,113],"capture":[97],"assays":[98,110],"followed":[99],"LC/MS":[101],"analysis.":[102],"Ligand":[103],"validated":[106],"through":[107,413],"protein-protein":[108],"binding":[109,144,189,220,236,258,271],"Biacore":[112],"measurements.":[114],"Through":[115],"an":[116],"immunization":[117],"campaign,":[118],"library":[120],"anti-CLEC-1":[122,157,251],"was":[125],"generated":[126],"screened":[128],"for":[129,138,165,344,389],"protein":[131],"binding.":[132],"Monoclonal":[133],"also":[136,206],"assessed":[137],"abilities":[140],"inhibit":[142],"its":[148,238,260,273,327,335],"newly":[149,225],"ligands.":[152,215,239],"Different":[153],"classes":[154,248],"antagonist":[156,250],"thereby":[160],"subsequently":[163],"evaluated":[164],"efficacies":[168],"hepatocellular":[170],"carcinoma":[171],"(Hepa1.6)":[172],"colorectal":[174],"cancer":[175,345,390],"(MC38)":[176],"preclinical":[177],"models,":[178],"human":[180],"knock-in":[182],"mice.Results":[183],"we":[185,205,241],"confirm":[186],"specific":[188],"E3":[192],"ubiquitin":[193],"ligase":[194],"TRIM21":[195],"2":[196],"secreted":[200,261],"histidine":[201],"rich":[202],"glycoprotein":[203],"(HRG),3":[204],"identify":[207],"several":[208,247],"novel":[209,339],"intra-cellular":[210],"surface":[213],"We":[216],"show":[217],"that":[218,378],"these":[224],"protein-specific,":[229],"deglycosylation":[231],"impair":[234,330],"Finally,":[240],"document":[242],"antitumoral":[244],"activities":[245],"antibodies:":[253],"while":[254],"blocking":[255],"HRG":[263],"moderately":[264],"responses,":[267],"inhibition":[268],"cytoplasmic":[274],"membrane":[275],"significantly":[277],"impairs":[278],"MC38":[279],"tumor":[280],"growth":[281],"(n=12,":[282,292],"p=0.04)":[283],"overall":[287],"survival":[288],"Hepa1.6-bearing":[290],"p=0.002),":[293],"compared":[295],"corresponding":[297],"isotype":[298],"control":[299],"treatment.Conclusions":[300],"Altogether,":[301],"shedding":[303],"new":[304],"light":[305],"on":[306],"role":[308],"CLEC-1/CLEC-1":[310],"interactions,":[312],"our":[313],"results":[314],"further":[315],"dissect":[316],"mechanism":[318],"action":[320],"ability":[328],"immunity":[332],"support":[334],"use":[336],"highly":[341],"promising":[342],"target":[343,388],"immunotherapy.References":[346],"Drouin":[347],"M,":[348,366,399],"Saenz":[349,367],"J,":[350,368],"Chiffoleau":[351],"E.":[352],"C-Type":[353],"Lectin-Like":[354],"Receptors:":[355],"Head":[356],"Tail":[358],"Cell":[360],"Death":[361],"Immunity.":[362],"Front":[363],"Immunol.":[364],"2020;11:251.Drouin":[365],"Gauttier":[369],"V,":[370],"et":[371,400],"al.":[372,401],"death":[376],"sensor":[377],"limits":[379],"represents":[386],"immunotherapy.":[391],"Sci":[392],"Adv.":[393],"2022;8(46):eabo7621.Gao":[394],"S,":[395],"Wake":[396],"H,":[397],"Sakaguchi":[398],"Histidine-Rich":[402],"Glycoprotein":[403],"Inhibits":[404],"High-Mobility":[405],"Group":[406],"Box-1-Mediated":[407],"Pathways":[408],"Vascular":[410],"Endothelial":[411],"Cells":[412],"CLEC-1A.":[414],"iScience.":[415],"2020;23(6):101180.":[416]},"counts_by_year":[],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2023-11-01T00:00:00"}